To strengthen Indonesia's position in the global research ecosystem, Equilab International as the Indonesian Contract Research Organization (CRO), has formalized the first strategic collaboration with the Clinical Research Unit (CRU) in National Brain Center Hospital (also known well as RS PON). This partnership synergizes the clinical operations capabilities and advanced laboratory analysis of both institutions to facilitate high-quality clinical research in Indonesia. For t

Equilab International recently took a role as a featured speaker at the RSUD Dr. Soetomo Research Hub 2025 event in Surabaya. The event held under the theme, “Build Hospital Reputation through Research.” The forum convened leading stakeholders from hospitals in East Java, the Ministry of Health (MoH), the National Agency of Drug and Food Control (BPOM), researchers, contract research organizations (CROs), and the pharmaceutical industries. The core discussion focused on strat

As a leading Bioequivalence Centre in Indonesia and Southeast Asia, Equilab International was honored to be one of the speakers at the Asia Pacific Pharma Executive Forum 2025, held in Nusa Dua, Bali, on October 15–16, 2025. Equilab’s Group Analytical Manager, Mr. Yantirta Indra Kurniawan, S.Si, M.Biomed, shared a presentation on “The Critical Role of the Bioanalytical Aspect in Drug Development” to participants from South East Asian countries, India, Japan, Korea, Australia,

Jakarta, 22 Oktober 2025 – Asosiasi Pengusaha Suplemen Kesehatan Indonesia (APSKI) melakukan kunjungan resmi ke Equilab International sebagai laboratorium pengujian di Indonesia  dalam rangka memperkuat sinergi di bidang pengujian suplemen, obat tradisional, dan produk kosmetik. Kunjungan ini menjadi langkah awal untuk kolaborasi yang mencakup uji klinis, laboratory testing , hingga dermatology testing , sebagai upaya meningkatkan standar mutu dan keamanan produk kesehatan di

Surabaya, 1 Oktober 2025  – Equilab International sebagai laboratorium pengujian kosmetik di Indonesia yang sudah terakreditasi ISO 17025...

Thank you for the trust from all of our customers, we are glad to announce that Equilab International is now listed in the "Top...

In a significant step toward advancing Indonesia's bioequivalence and clinical trial landscape, dr. William Adi Teja, MD, B.Med., M.Med....

Equilab International sebagai laboratorium pengujian di Indonesia yang sudah terakreditasi KAN ISO 17025 berpartisipasi turut hadir dalam...

In a continued effort to strengthen Indonesia’s clinical trial ecosystem, the Material Transfer Agreement (MTA) Committee of Indonesia's...

Equilab recently participated in the CRM Trial Connect 2025 event, held on May 8-9 in Kuala Lumpur, Malaysia. This prestigious conference...

On 3 February 2025, Equilab International, Indonesia's largest Contract Research Organization (CRO), proudly announces the signing of a...

JAKARTA - The Head of the National Agency of Drug and Food Control (BPOM), Prof. Dr. Taruna Ikrar, M.Biomed., Ph.D.,...